Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis.

Yool Hee Kim Ha Young Shin Seung Min Kim

Published in: Yonsei medical journal (2019)

Tacrolimus may be effective in reducing the severity of MG and may permit a reduction in the steroid dose prescribed to the patients. Adverse events due to tacrolimus treatment were not serious.

Keyphrases

myasthenia gravis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
combination therapy